UXS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.113200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.940400E-01
Normal-vs-Stage2
6.474400E-01
Normal-vs-Stage3
4.753800E-01
Normal-vs-Stage4
9.702400E-01
Stage1-vs-Stage2
3.656000E-01
Stage1-vs-Stage3
9.258800E-01
Stage1-vs-Stage4
3.084200E-01
Stage2-vs-Stage3
5.319800E-01
Stage2-vs-Stage4
5.593400E-01
Stage3-vs-Stage4
4.738200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.139600E-01
Normal-vs-AfricanAmerican
8.340800E-01
Normal-vs-Asian
4.167800E-01
Caucasian-vs-AfricanAmerican
7.148800E-01
Caucasian-vs-Asian
4.761000E-01
AfricanAmerican-vs-Asian
4.607000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.345800E-01
Normal-vs-Female
6.040400E-01
Male-vs-Female
9.990000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.778400E-01
Normal-vs-Age(41-60Yrs)
8.541200E-01
Normal-vs-Age(61-80Yrs)
3.928000E-01
Normal-vs-Age(81-100Yrs)
5.358600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.087600E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.322800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.765200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.555100E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.714190E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.796200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.416600E-01
Normal-vs-Daily Drinker
5.952400E-01
Normal-vs-Weekly Drinker
3.705000E-01
Normal-vs-Occasional Drinker
6.941600E-01
Normal-vs-Social Drinker
2.232400E-01
Non Drinker-vs-Daily Drinker
3.859800E-01
Non Drinker-vs-Weekly Drinker
8.075400E-01
Non Drinker-vs-Occasional Drinker
1.325570E-02
Non Drinker-vs-Social Drinker
7.425200E-01
Daily Drinker-vs-Weekly Drinker
6.027400E-01
Daily Drinker-vs-Occasional Drinker
9.169700E-02
Daily Drinker-vs-Social Drinker
5.275200E-01
Weekly Drinker-vs-Occasional Drinker
6.493700E-02
Weekly Drinker-vs-Social Drinker
9.909600E-01
Occasional Drinker-vs-Social Drinker
3.562000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.060000E-01
Normal-vs-Grade 2
1.431010E-01
Normal-vs-Grade 3
1.449960E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.385700E-02
Grade 1-vs-Grade 3
6.349800E-02
Grade 1-vs-Grade 4
5.060000E-01
Grade 2-vs-Grade 3
9.697600E-01
Grade 2-vs-Grade 4
1.431010E-01
Grade 3-vs-Grade 4
1.449960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.749800E-01
Normal-vs-NonDiabetic
5.859600E-01
Diabetic-vs-NonDiabetic
9.520400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.291600E-01
Normal-vs-NoPancreatitis
6.184800E-01
Pancreatitis-vs-NoPancreatitis
8.241400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.154400E-01
Normal-vs-N1
6.904800E-01
N0-vs-N1
4.267200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.539000E-01
Normal-vs-TP53-NonMutant
3.393200E-01
TP53-Mutant-vs-TP53-NonMutant
3.98780000000487E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
